These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
235 related articles for article (PubMed ID: 25721678)
1. Stereotactic body radiation therapy salvage reirradiation of radiorecurrent prostatic carcinoma relapsed in the prostatic bed. Arcangeli S; Gambardella P; Agolli L; Monaco A; Dognini J; Regine G; Donato V Tumori; 2015 Apr; 101(2):e57-9. PubMed ID: 25721678 [TBL] [Abstract][Full Text] [Related]
2. Salvage reirradiation for locoregional failure after radiation therapy for prostate cancer: who, when, where and how? Créhange G; Roach M; Martin E; Cormier L; Peiffert D; Cochet A; Chapet O; Supiot S; Cosset JM; Bolla M; Chung HT Cancer Radiother; 2014 Oct; 18(5-6):524-34. PubMed ID: 25192626 [TBL] [Abstract][Full Text] [Related]
3. Salvage hypofractionated radiotherapy for biochemically recurrent prostate cancer after radical prostatectomy. Wong GW; Palazzi-Churas KL; Jarrard DF; Paolone DR; Graf AK; Hedican SP; Wegenke JD; Ritter MA Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):449-55. PubMed ID: 17869014 [TBL] [Abstract][Full Text] [Related]
4. Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. Ghadjar P; Hayoz S; Bernhard J; Zwahlen DR; Hölscher T; Gut P; Guckenberger M; Hildebrandt G; Müller AC; Plasswilm L; Papachristofilou A; Stalder L; Biaggi-Rudolf C; Sumila M; Kranzbühler H; Najafi Y; Ost P; Azinwi NC; Reuter C; Bodis S; Kaouthar K; Wust P; Thalmann GN; Aebersold DM J Clin Oncol; 2015 Dec; 33(35):4158-66. PubMed ID: 26527774 [TBL] [Abstract][Full Text] [Related]
5. Hyaluronic acid spacer in focal prostate reirradiation: A single centre experience. Ozyigit G; Hurmuz P; Akinci D; Esen SCB; Yilmaz MT; Akdogan B; Akyol FH Cancer Radiother; 2020 Dec; 24(8):805-811. PubMed ID: 32565071 [TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience. Servoll E; Sæter T; Vlatkovic L; Nesland JM; Waaler G; Axcrona K Scand J Urol; 2015 Jun; 49(3):218-23. PubMed ID: 25428750 [TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated salvage radiotherapy with simultaneous integrated boost for local recurrence of prostate carcinoma: a pilot study on the place of PET-choline for guiding target volume delineation. Wahart A; Guy JB; Vallard A; Geissler B; Ben Mrad M; Falk AT; Prevot N; de Laroche G; Rancoule C; Chargari C; Magné N Br J Radiol; 2016; 89(1058):20150579. PubMed ID: 26648528 [TBL] [Abstract][Full Text] [Related]
8. Elective pelvic versus prostate bed-only salvage radiotherapy following radical prostatectomy: A propensity score-matched analysis. Song C; Kang HC; Kim JS; Eom KY; Kim IA; Chung JB; Hong SK; Byun SS; Lee SE Strahlenther Onkol; 2015 Oct; 191(10):801-9. PubMed ID: 26159555 [TBL] [Abstract][Full Text] [Related]
13. Salvage radiotherapy for biochemical and clinical failures following radical prostatectomy. Do T; Parker RG; Do C; Tran L; Do L; Dolkar D Cancer J Sci Am; 1998; 4(5):324-30. PubMed ID: 9815297 [TBL] [Abstract][Full Text] [Related]
14. Outcome after conformal salvage radiotherapy in patients with rising prostate-specific antigen levels after radical prostatectomy. Geinitz H; Riegel MG; Thamm R; Astner ST; Lewerenz C; Zimmermann F; Molls M; Nieder C Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1930-7. PubMed ID: 21514736 [TBL] [Abstract][Full Text] [Related]
15. Relationship between pelvic organ-at-risk dose and clinical target volume in postprostatectomy patients receiving intensity-modulated radiotherapy. Stanic S; Mathai M; Cui J; Purdy JA; Valicenti RK Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1897-902. PubMed ID: 21536391 [TBL] [Abstract][Full Text] [Related]
16. ¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients. D'Angelillo RM; Sciuto R; Ramella S; Papalia R; Jereczek-Fossa BA; Trodella LE; Fiore M; Gallucci M; Maini CL; Trodella L Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):296-302. PubMed ID: 25084612 [TBL] [Abstract][Full Text] [Related]
17. Improved outcomes with higher doses for salvage radiotherapy after prostatectomy. King CR; Spiotto MT Int J Radiat Oncol Biol Phys; 2008 May; 71(1):23-7. PubMed ID: 18207668 [TBL] [Abstract][Full Text] [Related]
18. Sooner or later? Outcome analysis of 431 prostate cancer patients treated with postoperative or salvage radiotherapy. Jereczek-Fossa BA; Zerini D; Vavassori A; Fodor C; Santoro L; Minissale A; Cambria R; Cattani F; Garibaldi C; Serafini F; Matei VD; de Cobelli O; Orecchia R Int J Radiat Oncol Biol Phys; 2009 May; 74(1):115-25. PubMed ID: 19004572 [TBL] [Abstract][Full Text] [Related]
19. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy. D'Agostino GR; Di Brina L; Mancosu P; Franzese C; Iftode C; Franceschini D; Clerici E; Tozzi A; Navarria P; Scorsetti M Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):614-621. PubMed ID: 30825495 [TBL] [Abstract][Full Text] [Related]
20. Higher-than-expected severe (Grade 3-4) late urinary toxicity after postprostatectomy hypofractionated radiotherapy: a single-institution analysis of 1176 patients. Cozzarini C; Fiorino C; Deantoni C; Briganti A; Fodor A; La Macchia M; Noris Chiorda B; Rancoita PM; Suardi N; Zerbetto F; Calandrino R; Montorsi F; Di Muzio N Eur Urol; 2014 Dec; 66(6):1024-30. PubMed ID: 24985964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]